Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Henry Schein, Inc.    HSIC

HENRY SCHEIN, INC.

(HSIC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • The group usually releases upbeat results with huge surprise rates.
  • As regards fundamentals, the enterprise value to sales ratio is at 0.99 for the current period. Therefore, the company is undervalued.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 72.13.
Ratings chart
Sector Medical Equipment Wholesale
1st jan.Capitalisation (M$)Investor Rating
HENRY SCHEIN, INC.-3.61%9 182
AS ONE CORPORATION57.10%2 872
CANTEL MEDICAL CORP.-16.18%2 511
SHIP HEALTHCARE HOLDINGS, I..2.97%2 351
OWENS & MINOR, INC.398.26%1 894
TOKAI CORP.-27.93%694
JAPAN MEDICAL DYNAMIC MARKE..0.47%593
More Results
Financials (USD)
Sales 2020 9 823 M - -
Net income 2020 401 M - -
Net Debt 2020 412 M - -
P/E ratio 2020 22,8x
Yield 2020 -
Capitalization 9 268 M 9 268 M -
EV / Sales 2020 0,99x
EV / Sales 2021 0,87x
Nbr of Employees 19 000
Free-Float 98,6%
Upcoming event on HENRY SCHEIN, INC.
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes